Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
Hernández-Molina G, Cachafeiro-Vilar A, Villa AR, Alberú J, Rull-Gabayet M. Transplantation. 2008 Dec 15;86(11):1543-7
Related Articles:
- Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
- Impact of Early Conversion From Tacrolimus to Sirolimus on Chronic Allograft Changes in Kidney Recipients on Rapid Steroid Withdrawal
- Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study.
Recent Comments